Fig. 3.
Fig. 3. Ideogram of gains and losses according to the genomewide array CGH in 12 FCL-derived cell lines. / Lines on the right of each ideogram indicate genomic gains, lines on the left show losses of chromosomal material, and high-level amplifications are symbolized by bold lines. Cell lines are indicated by numbers above each line and correspond to Karpas 231 (no. 1); OZ (no. 2); OCI-LY8 (no. 3); DOHH2 (no. 4); SUDHL6 (no. 5); PR1 (no. 6); Karpas 422 (no. 7); BEVA (no. 8); VAL (no. 9); Karpas 353 (no. 10); ROS50 (no. 11); and RL (no. 12). Black circles localize the regions commonly acquired upon transformation in patients with FCL.

Ideogram of gains and losses according to the genomewide array CGH in 12 FCL-derived cell lines.

Lines on the right of each ideogram indicate genomic gains, lines on the left show losses of chromosomal material, and high-level amplifications are symbolized by bold lines. Cell lines are indicated by numbers above each line and correspond to Karpas 231 (no. 1); OZ (no. 2); OCI-LY8 (no. 3); DOHH2 (no. 4); SUDHL6 (no. 5); PR1 (no. 6); Karpas 422 (no. 7); BEVA (no. 8); VAL (no. 9); Karpas 353 (no. 10); ROS50 (no. 11); and RL (no. 12). Black circles localize the regions commonly acquired upon transformation in patients with FCL.

Close Modal

or Create an Account

Close Modal
Close Modal